What is FDMT stock price today?

FDMT (4D Molecular Therapeutics Inc) stock is trading at $8.87 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is FDMT stock going up or down today?

FDMT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy FDMT stock now?

The decision to buy FDMT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is FDMT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for FDMT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is FDMT stock overvalued or undervalued?

Use our DCF valuation calculator to determine if FDMT is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is FDMT's P/E ratio?

P/E ratio data for FDMT will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is FDMT's market cap?

FDMT (4D Molecular Therapeutics Inc) has a market capitalization of $0.53 billion, making it a small-cap stock.

What is FDMT's price to book ratio?

FDMT trades at a price-to-book (P/B) ratio of 1.29, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does FDMT pay dividends?

FDMT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is FDMT's dividend yield?

FDMT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is FDMT stock a good long-term investment?

FDMT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is FDMT's revenue growth rate?

FDMT has shown revenue growth of 29.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for FDMT are available on our dashboard with complete income statement analysis.

What are the risks of investing in FDMT?

Key risks for FDMT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does FDMT compare to its competitors?

Compare FDMT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize FDMT's performance and positioning.

What is FDMT's stock price target for 2026?

Our AI model provides price targets for FDMT based on fundamental analysis: Bull case $11.53 (+30%), Base case $10.20 (+15%), Bear case $7.98 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about FDMT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for FDMT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is FDMT's next earnings report?

FDMT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

FDMT - 4D Molecular Therapeutics Inc

NYSE * Health Care * Biotechnology

$8.87

$-0.46 (-4.93%)

About 4D Molecular Therapeutics Inc

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in EmeryVille, California.

FDMT Key Statistics

Market Cap

$533.07M

P/B Ratio

1.29

EPS

$-3.75

Revenue Growth

+29.0%

Employees

227

How FDMT Compares to Peers

FDMT has the fastest revenue growth among competitors

FDMT is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
FDMT(This stock)	$533.07M	N/A	29%	0.0%	-
AMGNAmgen Inc	$207.92B	27.1	0%	0.2%	vs AMGN
GILDGilead Sciences	$186.25B	22.1	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$123.45B	31.7	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$83.60B	19.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$27.01B	21.4	-0%	0.1%	vs BIIB

4D Molecular Therapeutics Inc Company Information

Headquarters: California; U.S.A
Website: www.4dmoleculartherapeutics.com
Sector: Health Care
Industry: Biotechnology

FDMT - 4D Molecular Therapeutics Inc

About 4D Molecular Therapeutics Inc

FDMT Key Statistics

How FDMT Compares to Peers

4D Molecular Therapeutics Inc Company Information

FDMT Lician Score

FDMT Financial Snowflake

Upcoming Events for FDMT